​

vTv Therapeutics Ownership | Who Owns vTv Therapeutics?

OverviewForecastRevenueFinancialsChart

vTv Therapeutics Ownership Summary

vTv Therapeutics is owned by 8.68% institutional investors, 35.60% insiders, and 55.72% retail investors. Fidelity Select Biotechnology is the top mutual fund, with 6.82% of its assets in vTv Therapeutics shares.

VTVT Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockvTv Therapeutics8.68%35.60%55.72%
SectorHealthcare Stocks 279.19%10.62%-189.81%
IndustryBiotech Stocks 63.96%10.74%25.30%

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 20252017.65%571,7123.68%89.51%716.67%5-
Dec 31, 202417-15.00%551,4241.68%99.67%6-25.00%--100.00%
Sep 30, 2024205.26%542,32455.78%933.63%8-1-
Jun 30, 202419-348,1404.34%58.38%8-27.27%1-75.00%
Mar 31, 20241935.71%333,650386.02%874.31%11266.67%4-63.64%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Fidelity Select Biotechnology178.20K6.82%-
Vanguard Total Stock Mkt Idx Inv33.67K1.29%-
Vanguard US Total Market Shares ETF33.45K1.28%-211.00
Vanguard Institutional Extnd Mkt Idx Tr9.27K0.35%1.62K
Fidelity Extended Market Index5.72K0.22%702.00
Northern Small Cap Core I4.71K0.18%-194.00
iShares Micro-Cap ETF2.99K0.11%-
Fidelity Nasdaq Composite Index2.52K0.10%-
NT Quality SCC US Fund - L2.41K0.09%-62.00
NT Quality Small Cap Core2.41K0.09%-62.00

Recent Insider Transactions

DateNameRoleActivityValue
Nov 15, 2024SEKHRI PAUL J Pres, CEO and Exec ChairpersonBuy$22.53K
Nov 15, 2024SEKHRI PAUL J Pres, CEO and Exec ChairpersonBuy$30.01K
Nov 18, 2024SEKHRI PAUL J Pres, CEO and Exec ChairpersonBuy$31.27K
Nov 29, 2022FRY JOHN A-Buy$33.77K
Nov 28, 2022FRY JOHN A-Buy$16.97K

Insider Transactions Trends

DateBuySell
2025 Q2--
2025 Q1--
2024 Q43-
2024 Q2--
2024 Q1--

VTVT Ownership FAQ

Who Owns vTv Therapeutics?

vTv Therapeutics shareholders are primarily institutional investors at 8.68%, followed by 35.60% insiders and 55.72% retail investors. The average institutional ownership in vTv Therapeutics's industry, Biotech Stocks , is 63.96%, which vTv Therapeutics falls below.

Does Blackrock own vTv Therapeutics?

BlackRock is not among the top 10 institutional shareholders of vTv Therapeutics.

Who is the top mutual fund holder of vTv Therapeutics shares?

Fidelity Select Biotechnology is the top mutual fund holder of vTv Therapeutics shares, with 6.82% of its total shares outstanding invested in 178.2K vTv Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools